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I. Introduction 
 
  The last decade has seen a major shift in the research portfolios of agricultural 
colleges at land grant universities with more effort being dedicated to agricultural 
biotechnologies.  Land grant universities in the U. S. have gone from producing 1283 ag-
biotech articles per year and 16 patents in 1991 to 1780 articles and 105 patents in 2001.  
One incentive for a shift toward biotechnologies has been the possibility of universities 
gaining intellectual property rights, patents, and a potential revenue stream from ag-
biotech research.  This paper examines the empirical evidence for synergies or tradeoffs 
associated with the rapid rise of ag-biotech patenting at Land Grant Universities by 
examining the question of whether journal articles and patents appear to be 
complementary or competing activities in agricultural biotechnology research.   
Part of the logic of the Bayh-Dole act of 1980 that allowed universities to patent 
and license their innovations was that doing so would enhance rather than detract or 
distract from the scientific process.  Rausser (1999) reports that universities have 
responded to the Bayh-Dole act by expanding technology transfer activities in ways 
similar to private companies.  Henderson, Trajtenberg, and Jaffe have shown a reduction 
in the quality of patents produced by universities since the advent of the Bayh-Dole act, 
presumably due to the increased pressure to commercialize innovations.  Some have 
expressed concerns over an increase in secrecy in the scientific community due to 
patenting (see e.g. Kennedy, 2000). 
 In the case of Land Grant universities, Parker and Zilberman present concerns 
that incentives to patent might shift university professors’ research agendas away from 
the pursuit of public knowledge and toward patentable innovations.  Weatherspoon,   2
Oehmke, and Raper (2000) argue that commercialization of Land Grant research agendas 
moves them away from their mission of conducting and disseminating unbiased research 
for the public good and toward serving narrower private purposes.  In addition, some of 
the popularly voiced opposition to agricultural biotechnology has suggested that 
patenting by public sector institutions induces too much applied, commercial, research at 
the expense of farmer-oriented research (see e.g. RAFI, 2000).  If such an increased 
commercialization and a concomitant turning away from basic research were underway, 
it would represent a major shift in the historic mission of the Land Grant system.   
Despite these concerns with the potential problems associated with university 
patenting in general and ag-biotech patenting in particular, little direct empirical evidence 
has been provided on tradeoffs associated with the rise of ag-biotech patenting at Land 
Grant universities.  One potentially obvious tradeoff would be in terms of journal article 
production, whereby the pursuit of patentable innovations would crowd out the process of 
drafting, submitting, and revising journal articles for publication because of competing 
time pressures and/or for reasons of keeping certain scientific advances secret prior to 
securing patents.  Another possible tradeoff is that the quality of journal articles might 
decline with increased patenting effort because of the shift toward more applied research 
associated with the pursuit of commercial innovations.   
Conversely, synergies might be more important than tradeoffs, if the underlying 
output of research knowledge is recognized as an input that can be used to generate both 
journal articles and patents, and that the two activities can thus be pursued jointly without 
much crowding out, as long as a capable technology transfer office exists to carry 
shoulder the burden of the patenting process.  Where these synergies, or economies of   3
scope, dominate tradeoffs, or any diseconomies of scope, then both the quantity and 
quality of patents and journal articles could be positively correlated with one another.   
  In previous work, we demonstrated that the recent takeoff in ag-biotech patenting 
among U.S. universities was fairly highly concentrated in the hands of a few major Land 
Grant institutions (Barham, Foltz, and Kim).  We also found that ag-biotech patent output 
is supported by previous patenting experience, efficiency of patenting efforts, and 
economies of scope with the biological sciences, as well as by more traditional research 
production variables, such as federal funding and the quantity and quality of researchers 
(Foltz, Kim, and Barham).  In other words, some of the variables shaping university ag-
biotech patent production are suggestive of the presence of increasing returns due to 
either scale and/or scope effects.  Similar scale effects may be prevalent in private 
industry where ag-biotech companies consolidated to a significant extent in the recent 
decade (add citation here).  More direct evidence of increasing returns is identified in the 
seed industry by Graff, Rausser, and Small, who find significant production 
complementarities in firms that control both conventional germplasm and ag-biotech 
patents.  Our hypothesis is that synergies dominate tradeoffs in the case of university 
journal article and patent production because the key input for both is high quality 
research knowledge that can be applied to produce both outputs jointly. 
The efficiency and equity implications associated with this issue are significant. 
First, if synergies are dominant, then there are efficiency grounds for supporting the 
increased emphasis of universities on patent production that may not be receiving 
sufficient attention.  Second, if increasing returns within the agricultural biotechnology 
research process of Land Grant universities are present both in terms of scope and scale,   4
then it is not hard to imagine the top producers capturing the dominant share of 
university-level benefits associated with this line of research in a virtuous, dynamic cycle 
of more, high quality research production fueling future research successes.
2  This 
prospect will be bolstered, especially if the ag-biotech patents payoff in the form of 
licensing revenues, sponsored research agreements, and successful start-up ventures, such 
that universities with more patents can pursue even more research with the support of 
these funds.  Such a cycle is both socially attractive because of the efficiency gains 
associated with increasing returns but also potentially troubling in its implications for the 
future vitality of those Land Grant universities which cannot get up to the scale of 
research production that allows them to exploit the increasing returns. Because Land 
Grant universities are also the leading providers of high-end university education and 
extension work, a growing disparity among them fueled by divergence in the research 
realm could be of broader concern. 
  This work must be regarded as an exploratory empirical inquiry into the 
relationship between ag-biotech patent and article production in Land Grant universities 
that uses both quantity and quality measures to identify the potential synergies or 
tradeoffs involved.  Rather than a definitive piece testing a formal model of economies of 
scope and scale (cites), it is intended as a first step in guiding future research on the issue 
of increasing returns within university research production processes.  In that spirit, we 
employ non-parametric regression techniques that allow the production data to indicate 
                                                 
2 Baumol argues that the technological dynamism of the modern capitalist system stems primarily from the 
systematic nature of research production that has come to dominate in both the private and public sectors 
over the past century, and that this process tends to be self-reinforcing within successful research 
institutions.   5
the potential presence or lack of increasing returns, i.e., the economies of scope and scale 
that are our focus.   
  We use two quantitative outputs, journal articles and US patents, but also their 
qualitative counterparts: the number of citations of those patents and journal articles.
3  
The analysis starts by demonstrating the dramatic but staggered growth paths of 
university ag-biotech patents and articles in the 1990s.  This is followed by an 
investigation of increasing returns in the production of articles and patents.  Two types of 
increasing returns are examined: scope in which higher levels of article production are 
associated with higher levels of patent production; and scale in which higher quantities of 
patents (articles) produces higher quality patents (articles).  Finally, we close the circle by 
analyzing the relationship between quality measures of articles and patents in order to see 
whether the economies of scale and scope serve to reinforce the advantageous position of 
the top-research producing universities. 
 
II. Data and methods:   
  The data used in this study were collected from two sources: the US Patent and 
Trademarks Office (USPTO) for patents and from the Science Citation Index (Web of 
Science) database for articles.  Articles and patents were chosen so as to produce a 
consistent dataset that would represent the majority of research considered to be 
agricultural biotechnology.  Both searches were conducted in two basic steps.  First,  
articles (patents) credited to researchers at Land Grant institutions were identified as 
                                                 
3 Some strands of the literature (e.g. Cockburn, Henderson, and Stern, 1999; and Xia and Buccola, 2000 ) 
call patents “applied” research and journal articles “basic” research.  It is not clear, especially at Land Grant 
universities where research articles on applied topics are the norm, that this distinction is as clear cut.  The 
primary key distinction is the intellectual property on patents which restricts access and increases 
commercial potential in a way not applicable to journal articles.    6
being on biotechnology topics.  Then, within the realm of biotechnology, articles and 
patents were chosen for inclusion if they were identified as pertinent to agriculture. 
Specifically, the patent data were drawn from a search of the U.S. Patent office 
database for university-owned utility patents that were both agricultural and 
biotechnological.
4  We considered all patents in U.S. classes 435, 800, 935 as biotech and 
then searched within them for those that were agricultural.  The definition of agriculture 
we used required that the technology: 1) uses extensively a product produced on a farm; 
or 2) modifies or improves a product produced on a farm; or 3) modifies, improves, or 
produces a food, wood, or aquaculture product.  Note that this definition excludes a 
number of technologies including: (i) any animals or plants produced entirely for research 
purposes (e.g., mice, rats, monkeys); (ii) any animal primarily designed as a pet: e.g. dogs 
and cats; (iii) any product that merely uses animal or plant cells in minor quantities for a 
non-agricultural product; or (iv) any vaccine or vaccine technique or disease diagnostic 
technique that is intended primarily for use in humans, or on human diseases, or on 
diseases not currently treated in animals.  Note that the database does include utility 
patents on plants intended only for ornamentation so long as they fit the definition of 
being biotechnology.   
The ag-biotech articles were culled from the Science Citation Index (ISI Web of 
Science, 2002).  Articles were chosen by key words related to biotechnology genetic 
modifications (genet*, gene, genom*) and then searched for agricultural topics.
5  The 
                                                 
4 While these data include utility patents on plants, plant variety protection and plant breeders rights were 
excluded because they represent a much lower level of intellectual property protection as well as lower 
levels of novelty required for a successful application. 
5 We experimented with a number of other key words for the search including: enzyme, protein, RNA, 
DNA, and transgenic.  These key words were rejected for greatly increasing the size of the set of 
biotechnology papers over which to search for agricultural topics without significantly increasing the 
number of agricultural biotechnology articles found.     7
same definition of agriculture was used as in the patent search, with some slight 
modification given that articles do not represent final products in the same way that 
patents do.  We culled from among those identified as biotechnological, all articles that 
included (1) basic and applied genetics, genomics, breeding, physiological or 
pathological studies of: plants (e.g. arabidopsis), crops (e.g. potato, tomato, barley, rice, 
maize, soybean, tobacco, alfalfa, etc.), vegetables (e.g. cabbage, cucumber, onion, etc. ), 
fruits (e.g. citrus, berries, grapes, apples, melons, etc.), seeds, weeds, or grasses; (2) 
genetic or medicinal studies related to farm animals such as: cows, pigs, chickens, sheep, 
rabbits, horses; (3) Studies on insects, viruses, fungi, or bacteria that are related to the 
pathology of plants, crops, or farm animals (includes veterinary medicine); (4) genetic 
technologies or research related to food production or food poisoning; (5) forestry 
research.  Research types that were excluded were: (1) marine plant biology; (2) research 
on aquatic life such as sea-urchin or fish (e.g. rainbow trout, zebrafish, etc.); (3) 
entomology related to human diseases; (4) veterinary medicine related to cats, dogs, or 
other pet animals; (5) genetic studies on wildlife species such as pigeons, condors, or 
songbirds; (6) genetic studies of amphibians such as snakes, salamanders, or lizards. 
The search yielded 718 ag-biotech patents assigned to 52 Land Grant universities 
between 1991 and 2001.  Over that same period 18,577 ag-biotech articles were 
identified as belonging to authors at those same universities.  Both article and patent 
counts credit a university with a single patent or article if at least one author is affiliated 
with the institution.  While necessarily adding some noise to the data, we decided that 
any other scheme for crediting authors would cause its own problems of equal or greater 
magnitude.     8
The patent and article data were then used to search for citations. Studies of patent 
citations have been to provide a reasonable proxy for both the quality of a patent and 
knowledge spillovers from it, because each time a new patent uses a piece of research 
from another patent it is obligated to cite the previous patent (Henderson, Jaffe, and 
Trajtenberg). Article citations are commonly used as measures of quality in studies of 
departmental or university quality (e.g. Adams).
   Despite their wide use, caution in 
interpreting citations as strong quality measures is warranted.  As the editor of the journal 
Science recently wrote: “Citation indices…are easily misjudged: Some of our best papers 
are lightly cited, and some less important ones get referenced everywhere.” (Kennedy, 
2002, p. 1193) 
 
Methods: 
Strict evidence of increasing returns depends on finding that unit costs fall with 
increased output over a substantial range of production.  The distinction between 
economies of scale and economies of scope as sources of increasing returns is that, in the 
former, unit costs of one output fall with increased output of that product whereas, in the 
latter, unit costs of two or more outputs fall as they are produced together.  Underlying 
these declining unit costs could be some significant (fixed or non-rivalrous) input that is 
spread over more output of one or more products, such as research knowledge applied to 
two or more outputs, or else improved efficiency that arises with more production such as 
dynamic learning effects. 
This empirical inquiry does not involve any formal measure of costs associated 
with university research production.  As such, the evidence offered cannot be viewed as   9
conclusive with regards to the presence or lack of increasing returns.  Rather, what is 
searched for in this inquiry is evidence that is consistent or not with economies of scope 
and scale in the production of articles and patents.  In particular, a positive and increasing 
slope in the production of articles and patents is viewed as consistent with economies of 
scope.  That is, more output of one output gives rise to more output of another at an 
increasing rate.  In the case of economies of scale in the production of patents and 
articles, we examine whether universities with more of either output are getting a higher 
quality output as measured by a higher citation rate per article or patent.  If they are, then 
that suggests the presence of economies of scale: universities receive a better average 
product when they produce more.  Finally, we test to see whether universities with higher 
quality articles also have higher quality patents, i.e. whether the other synergies are 
reinforcing, creating the potential for a virtuous cycle of universities with more research 
production getting higher quality outputs in both arenas.  
To search for evidence consistent with increasing returns or synergies, we employ 
a non-parametric approach that places a minimum of assumptions on the relationships 
between the variables.  This approach allows the data more “degrees of freedom” than the 
conventional parametric regression in which the justification of a model specification is 
often required (Manski; Blundell and Duncan).   This flexible technique allows the data 
to show the underlying relationship between the variables in question without imposing 
them a-priori through ad-hoc functional forms.  
Following Blundell and Duncan the general model of interest in this paper, with 
for example y measuring university patents and the variable x articles, is given by: 
y=g(x) + ε   10
where ε is defined such that E(ε|x) = 0.  Non-parametric regression allows us to avoid 
imposing parametric assumptions or restrictions on the function g(x), the conditional 
mean.  Instead, the conditional mean g(x) is replaced by a local estimator of the form: 
  ∫ ∫
∫ = = ,
) , (
) , (
) | ( ) | (
dy x y f
dy x y yf
dy x y f y x y E  
where f(y|x) is the conditional density of  y.  The numerator and the denominator are then 
replaced by a locally based Gaussian kernel estimator, 
6 
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where y is the random variable of interest, x is the conditioning variable, Kh is the 
Gaussian kernel with bandwidth h which we set to (4/n*(m+2))
1/(4+m),  and n and m are 
the number of observations and the number of columns in x, respectively.  
 
III. Trends in articles and patents 
 
Barham, Kim, and Foltz demonstrate a “take-off” in ag-biotech patenting in the 
mid-1990’s, and  Figure 1 below shows the growth in both accepted patents and 
published articles in ag-biotech from 1991-2001.  Clearly, there is a take-off in article 
production that pre-dates the growth in patenting.  The two curves suggest a four-to-five 
year gap between the initial growth spurt in ag-biotech articles and the subsequent growth 
                                                 
6 A number of alternate estimators are available for estimating the kernel function including the 
Epanechnikov and Parzen estimators.     11
spurt in patents.   The parallel “S” curves would seem to point toward synergies, perhaps 
lagged, between articles and patents. 
Both curves demonstrate a type of “S” curve in which after an initial rapid growth 
period production levels off, with article production remaining more or less constant from 
1995-2000 and patents dropping from their peak in 1999 but staying above 1997 levels.  
Both curves suggest that the growth spurt in ag-biotech research overall has leveled off in 
the later part of the 1990’s.   In the case of articles, this leveling off may be caused by 
maximum number of pages in the journals likely to publish ag-biotech articles or journal 
editors allocating a maximum number of pages within a journal to ag-biotech.  With 
patents, the spike in patenting in the late 1990’s coincides with the height of the (as yet 
unrealized) euphoria on the commercial potential of ag-biotech.  While it is unclear 
whether a downturn in patenting is underway, the 1990s growth spurt in university ag-
biotech patents seems to have ended.  Many explanations are possible including: the easy 
fruit have been picked from the article shelf, patenting is harder to do because of patent 
stacking or hold-ups (Graff and Zilberman?), and/or technology transfer offices are 
reacting to lowered commercial expectations in ag-biotech by seeking fewer patents.   
 
IV. Economies of Scope in Articles and Patents: Trade-offs or Synergies? 
 
This section investigates the trade offs and synergies between article and patent 
production.  In particular we search for evidence that patenting might be inhibiting article 
production, or that there might be opportunity costs in terms of article production in 
choosing to do patentable research.  We investigate these issues first at the level of all US   12
land grant universities, pooling their data together over time, and then at the individual 
university level.   
Before presenting the results, it is worth considering the question of the 
appropriate counterfactual.  Since all universities in the sample were active in both 
articles and patenting, one does not observe the counterfactual of universities producing 
only one or the other.  Thus, the available data are similar to an experiment with a 
treatment but no control subjects.   
 
1. Global: Non-parametric curve of articles versus patents 
 
  Two non-parametric estimates of the relationship between patents and article 
production are presented in Figure 2, with one curve showing 1991-1995 and the other 
1996-2000.  The estimation describes the number of ag-biotech patents at a particular 
university as a function of the number of ag-biotech articles produced at that university in 
the same period.  Both curves show distinct upward trends, in which universities with 
more articles produce more patents.  In the latter period that relationship became stronger 
and strongest among the universities producing the most articles.  Globally, there is no 
sign of a tradeoff among these activities but rather an outcome that seems more consistent 
with robust growth of joint products from a shared research production process. 
  Perhaps most striking about the relationship between patent and article production 
is that there seems to be a threshold at just below 50 articles per year, above which 
increasing synergies occur.  Put differently, it would seem that the synergies between 
articles and patents grow with more production of articles, i.e. that the economies of   13
scope may kick in at higher levels of research production.  Whether these increasing 
returns are due to higher quality research or fixed costs, i.e. that universities producing 
more articles are also better able to invest in the technology transfer infrastructure 
necessary to be successful in patenting is an issue we consider further in section VI.   
  
2. University Specific Economies of Scope 
 
  While Figure 1 shows the time trend and Figure 2 shows the overall relationship 
between articles and patents, the global estimates may mask some synergies or trade-offs 
taking place at individual universities.  Figure 3 shows, at the level of individual 
universities, the changes in article and patent production from the first to the second half 
of the 1990’s.  This provides a picture of both potential synergies or trade-offs and how 
those relationships might have changed between the first and second half of the decade of 
the 1990’s.  Arrows are provided for only a few universities so as not to confound the 
reader.  At the individual university level, the same growth trend in patenting that is 
evident at the global level is very clearly evident.  Almost all individual (98 %) land grant 
universities increased their patent production from the period 1991-1995 to 1996-2000.  
All of the universities producing more than 50 articles per year had significant increases 
in patent production.  A number of mid-level article producers such as Rutgers University 
and Louisiana State University had significant increases in their production of patents.  In 
addition, Michigan State University and Iowa State University had spectacular increases 
in patent production in the 1990s.      14
  Most of the universities dramatically increased their patent production while 
either maintaining their article production or increasing it, providing evidence of 
synergies.  Universities such as Rutgers, Wisconsin, Florida, and North Carolina State 
show at least 20% increases in articles and more than a 50% increase in patents produced, 
underscoring the apparent complementarity between the two activities.  This provides 
evidence, if not of synergies, at least that there are not significant trade offs between 
patents and articles.   
Most of the universities that exhibit the combination of significantly more articles 
along with more patents were high article producers (more than 50 per year) in the early 
period.  This suggests, as Figure 2 did on an aggregate level, that there may be some 
thresholds to the synergy between articles and patents.  In other words it is possible that 
one needs to produce a large number of ag-biotech articles to be able to generate strong 
synergies with patent production.  Such thresholds to synergy might partially explain the 
strong position of the major land grant universities, such as UC-Davis, Cornell, Iowa 
State, and Wisconsin in ag-biotech patenting since they are also the major article 
producers.  In order to be confirmed, these relationships deserve structural econometric 
exploration that would include estimates of the determinants of both research products.  
A few universities show some slight evidence of trade offs.  In particular Cornell, 
Montana, and Illinois have reduced ag-biotech article production while increasing 
patenting.  These three universities represent different slices of the article production 
spectrum, with average yearly production rates of 14.5 at Montana, 45.7 at U. of Illinois, 
and 127.2 at Cornell, the leading producer of ag-biotech articles.  While it is conceivable 
that Cornell researchers or administration might have pursued patenting at the expense of   15
article production, they nonetheless remained as the leading Land Grant university 
producer of ag-biotech articles. 
 
V. Economies of Scale in Articles and Patents? The quantity and quality 
relationship 
  
This section uses the citation rate of articles and patents as a measure of the 
quality of the articles or patents, and explores whether universities that produces more 
articles (patents) also produce higher quality articles (patents).  Such a relationship, if 
present, would give evidence of economies of scale in the quality of research outputs.   
 
Measuring quality: 
  In keeping with the established patent literature (e.g., Cockburn, Henderson, and 
Stern, and Henderson, Jaffe, and Trajtenberg) and the practice in most studies of 
departmental or university quality (e.g. Adams), we use the number of citations of an 
article or patent as the best available measure.
7  Since citations are time dependent with, 
for example, older articles receiving more citations than newer ones, we construct a 
citation measure for each university that is the deviation from the average citation rate of 
the average article published in the that year.  For example, a 1995 ag-biotech article with 
10 citations is compared to the average level of citations of all ag-biotech articles 
produced in 1995.  In any one year the overall average citation rate is assigned a value of 
                                                 
7 Citations are necessarily an imperfect measure because some very innovative articles may get few 
citations because they are not part of an established literature, while other articles such as review articles 
may be highly cited not because of their quality or degree of innovation but because they provide a 
convenient citation for authors.   16
1, with higher quality articles then having a measure greater than one and lower quality 
articles receiving a measure between zero and one.  This approach helps to minimize a 
bias that might exist for universities that had more articles late in the decade than early 
on.
8  Note that when aggregated and averaged across years at the university level, the 
distribution no longer necessarily centers on one.   
 
Estimates of quantity/quality relationships: 
 
  In order to show the relationships between quantity and quality of articles and 
patents we estimate two non-parametric kernel curves: one each for articles and patents 
showing the relationship between the quantity and quality.  Figure 4 shows, for the first 
and second half of the 1990’s, non-parametric regression curves of the relationship 
between the number of journal articles produced by a university and the average quality 
of those articles as measured in deviations from the yearly means.  The curves both show 
similar upward trends suggesting that universities producing more ag-biotech articles are 
also producing articles that on average are more highly cited.  Both curves are steeply 
sloped for the region below 20-30 articles per year, suggesting increasing returns to scale 
for relatively low levels of article production.  Most of the returns to scale disappear after 
30 articles per year, though both curves show positive slopes over most of the range. 
                                                 
8 If major universities or departments are more likely to have their work cited faster because their 
professors are more famous if perhaps not necessarily producing higher quality work, there may be a slight 
tendency for this measure to over count citations at the leading universities.     17
  Scale economies in patenting are investigated in Figure 5, which shows the 
relationship between the number of patents and their average citation rate.
9  Both periods 
show a distinctive pattern with universities that produce more patents also having higher 
quality patents.  The University of Florida adds an extra local spike to the 1991-1995 
curve which is generally above the 1996-2000 curve.  The 1996-2000 curve shows some 
evidence of a threshold effect, with only a slight positive relationship between patent 
numbers and patent citations up to about 2 patents per university per year, after which 
point patent quality is strongly increasing in the number of patents produced.    
  Taken together Figures 4 and 5 suggest via quality measures strong economies of 
scale in the production of ag-biotech patents and weaker economies of scale in the 
production of articles.
10  Put differently, in contrast to the literature, which suggests a 
quantity-quality tradeoff in patenting, the evidence from Figure 5 suggests that, as with 
articles, universities producing more patents are also producing higher quality patents. 
  
VI. Quality Tradeoffs or Synergies: 
 
 This  section  investigates  whether there are tradeoffs or synergies in the quality of 
articles and patents.  The first exercise is to investigate whether quality article production 
translates into more patents.  The second part analyzes whether there is a direct 
relationship between quality articles and quality patents. 
                                                 
9 Universities without any patents have been dropped from the estimation since their citation rate is 
necessarily zero. 
10 Note that some of this difference may come from the differences of purposes between patents and 
articles.  Journal editors are explicitly looking to publish articles that will be cited, which should produce a 
fairly uniform distribution of average citation rates.  In contrast patent inspectors are tasked with choosing 
innovations that meet the patenting criterion, novel and useful, which may not necessarily produce patents 
that will be cited in any uniform pattern.       18
In section (IV) Figure 2 shows patents to be produced in a ratio of about 1 patent 
per 20 or 30 journal articles.  Since patents explicitly require a degree of novelty that is 
stronger than the average scientific journal, there may be a positive relationship between 
the quality of articles and the quantity of patents produced.  For example, universities 
with higher quality articles may be more likely to produce patentable ideas. 
  At the same time there are suggestions in the literature (e.g. Brown), although 
little supporting empirical evidence, that an increase in commercial research agendas, as 
evidenced by patenting, has reduced the quality of scholarly production, i.e. articles.  
Such a trend, if real, would have universities that are devoting increasing efforts toward 
patenting having lower levels of citations of their journal articles as they produced more 
commercial, or applied, research rather than basic research, which is thought to be more 
frequently cited.   
  Figure 6 shows the relationship between article quality and patent production 
(quantity).  While the early period curve shows no distinctive trend in patent production 
across article quality, the later 1996-2000 curve shows a positive slope.  The results 
suggest some sort of positive correlation between article quality and the production of 
patents at universities.  This relationship, when understood along with the positive 
relationship between article quality and quantity, would reinforce some of the inequality 
increasing relationships mentioned above.  
  In the preceding sections, the quantity measures used have not accounted for the 
number of scientists engaged in ag-biotech research because such data are not readily 
available.  The data have effectively demonstrated quantity/quantity synergy and 
quantity/quality synergies, but some of these synergies may be caused by correlations in   19
scientist numbers rather than by actual synergies in the production process.  Since the 
citation rates of both patents and articles are item specific and independent of the number 
of scientists, analyzing the relationship between article quality and patent quality 
provides a clean measure synergies in the quality of research outputs. 
  Figure 7 shows a non-parametric estimate of the relationship between article 
citations and patent citations.  Both curves show general upward trends, although in the 
first half of the decade the last data point of the distribution shows a negative 
relationship.  Aside from that single data point, both curves show increasing slope at 
higher levels of article quality.  These estimates reinforce the notion that article and 
patent production are synergistic activities.  In particular, it would seem that high quality 
in articles is correlated with high quality of patents.  Given that quality is also associated 
with quantity in both cases, especially patents, this finding would seem to close the circle 
on the notion that universities at the high end of patent and article production are also 
producing higher quality outputs that are likely to foster further success in competitive 
grant processes, sponsored research agreements, and patent revenues. 
 
VII. Conclusions: 
This work has explored potential synergies and tradeoffs in the production of ag-
biotech journal articles and patents at US Land Grant universities using non-parametric 
methods.  The results show none of the expected tradeoffs between the basic research 
represented in journal articles and the commercial proprietary research represented in 
patents.  In fact the results, contrary to many of the concerns expressed in the literature, 
suggest significant synergies between articles and patents in the ag-biotech field.  There   20
may still be tradeoffs between basic and applied research in ag-biotech at Land Grant 
universities.  If they exist, they likely reside not at the university level, but at the 
individual scientist or lab level. 
This work has, however, identified a potential cause for concern in the degree to 
which patent and article production exhibit increasing returns in both scope and scale.  
Such a finding reinforces a pattern of inequality already found in the competitive grant 
system.  If the production of patents provides universities with another revenue source, 
then the types of inequalities that many USDA grant policies fight against, may be 
exacerbated. 
The evidence on the relationship between basic and applied research provided by 
this data exploration opens a number of questions for future inquiry.  The finding of 
synergies between articles and patents needs further analysis to help understand its 
determinants.  In addition it may be that while there are synergies between articles and 
patents, it is worth investigating tradeoffs with other common university activities such as 
teaching and extension.   
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